Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
41 hedge funds and large institutions have $10.7M invested in Albireo Pharma Inc in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
11% more funds holding
Funds holding: 37 → 41 (+4)
8% less capital invested
Capital invested by funds: $11.6M → $10.7M (-$906K)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
86% less call options, than puts
Call options by funds: $16K | Put options by funds: $111K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.4M |
| 2 |
FNYS
First New York Securities
New York
|
+$520K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$115K |
| 4 |
FMA
FNY Managed Accounts
New York
|
+$61.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$887K |
| 2 |
Renaissance Technologies
New York
|
-$311K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$136K |
| 4 |
CC
Cannell & Co
New York
|
-$69.2K |
| 5 |
D.E. Shaw & Co
New York
|
-$27.2K |
ALBO Hedge Fund Activity: Q3 2014 in Review
41 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2014, worth a combined $10.7M — down 7.8% from $11.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ALBO positions and 1 closed out — a net gain of 4 holders — while 10 added to existing stakes and 13 trimmed.
The largest buyer was Sabby Management, adding an estimated $2.4M. The largest seller was William Blair & Company, cutting an estimated $887K.
- 41 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2014, up from 37 in Q2 2014.
- Funds reported $10.7M of Albireo Pharma Inc stock for Q3 2014, down 7.8% quarter-over-quarter.
- 5 funds opened new Albireo Pharma Inc positions in Q3 2014 and 1 closed out, a net change of +4 holders.
- The largest Albireo Pharma Inc buyer in Q3 2014 was Sabby Management, an estimated $2.4M added.
- The largest Albireo Pharma Inc seller in Q3 2014 was William Blair & Company, an estimated $887K sold.
Based on aggregated 13F filings for Q3 2014.